Annieke C G van Baar, Jacques Devière, David Hopkins, Laurent Crenier, Frits Holleman, Manoel P Galvão Neto, Pablo Becerra, Paulina Vignolo, Leonardo Rodriguez Grunert, Geltrude Mingrone, Guido Costamagna, Max Nieuwdorp, Caterina Guidone, Rehan J Haidry, Bu Hayee, Cormac Magee, Juan Carlos Lopez-Talavera, Kelly White, Vijeta Bhambhani, Emily Cozzi, Harith Rajagopalan, Jacques Jghm Bergman
AIMS: Duodenal mucosal resurfacing (DMR) is an endoscopic procedure developed to improve metabolic parameters and restore insulin sensitivity in patients with diabetes. Here we report long-term DMR safety and efficacy from the REVITA-1 study. MATERIALS AND METHODS: REVITA-1 was a prospective, single-arm, open-label, multicenter study of DMR feasibility, safety, and efficacy in patients with type 2 diabetes (hemoglobin A1c [HbA1c] of 7.5-10.0% (58-86 mmol/mol)) on oral medication...
January 12, 2022: Diabetes Research and Clinical Practice